OS Therapies Incorporated
OSTX · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,880 | -$4,537 | -$3,877 | -$2,991 |
| Dep. & Amort. | $0 | $113 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $815 | $905 | $941 | $0 |
| Change in WC | $1,036 | $1,451 | -$299 | $313 |
| Other Non-Cash | $322 | -$292 | -$208 | $302 |
| Operating Cash Flow | -$4,706 | -$2,360 | -$3,442 | -$2,375 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$316 | -$150 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $24 | -$24 | $0 |
| Investing Cash Flow | $0 | -$293 | -$174 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$2,483 | $0 | $0 | $6,050 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $6,264 | $2,483 | $0 | $0 |
| Financing Cash Flow | $3,781 | $2,484 | $1,053 | $6,050 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$925 | -$169 | -$2,563 | $3,675 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,802 | $2,971 | $5,534 | $1,858 |
| End Cash | $1,877 | $2,802 | $2,971 | $5,534 |
| Free Cash Flow | -$4,706 | -$2,677 | -$3,592 | -$2,375 |